Enterprise Financial Services Corp (EFSC)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-23
Closed -$1K – 782
2021
Q2
$1K Buy
23
+12
+109% +$470 ﹤0.01% 1242
2021
Q1
$0 Hold
11
– – ﹤0.01% 1384
2020
Q4
$1K Hold
11
– – ﹤0.01% 1211
2020
Q3
$1K Hold
11
– – ﹤0.01% 1184
2020
Q2
$1K Hold
11
– – ﹤0.01% 1195
2020
Q1
$1K Sell
11
-89
-89% -$4.96K ﹤0.01% 1162
2019
Q4
$6K Hold
100
– – ﹤0.01% 822
2019
Q3
$6K Hold
100
– – ﹤0.01% 817
2019
Q2
$6K Hold
100
– – ﹤0.01% 857
2019
Q1
$8K Buy
+100
New +$6.45K ﹤0.01% 793
2016
Q1
– Sell
-105
Closed -$7K – 1095
2015
Q4
$7K Buy
+105
New +$5.67K ﹤0.01% 644

Other funds holding IONS

Enterprise Financial Services Corp (EFSC)'s IONS Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 23 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in IONS in Q4 2015 and held it in 11 quarters. The position peaked at $8K in Q1 2019. 325 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 23 Ionis Pharmaceuticals shares in Q3 2021, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 11 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Ionis Pharmaceuticals position peaked at $8K in Q1 2019.
  • 325 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.